Day: March 2, 2026

us corporate news

Digi Power X Inc. Shifts from Bitcoin Mining to AI Data Centers, Announces $150M Revenue Potential and Strategic Partnerships in 2026

Minichart

March 2, 2026

Digi Power X Inc. Announces Major AI Infrastructure Mileston...

Continue Reading 0

us corporate news

Signing Day Sports, Inc. Files Form 8-K Current Report with SEC – Company Details, Stock Information, and Regulatory Compliance 3

Minichart

March 2, 2026

Signing Day Sports, Inc. 8-K Report Analysis Signing Day...

Continue Reading 0

us corporate news

Aeries Technology Announces $5 Million Share Repurchase Program to Enhance Shareholder Value

Minichart

March 2, 2026

Aeries Technology, Inc. Announces \$5 Million Share Repurcha...

Continue Reading 0

us corporate news

Rayonier Inc. Files 8-K Report and XBRL Exhibits for March 2026 – SEC Filing Details and Disclosure Information

Minichart

March 2, 2026

Rayonier Inc. Issues Investor Presentation Highlighting Stra...

Continue Reading 0

us corporate news

Pulmatrix Terminates Cullgen Merger, Pursues Alternative Merger Opportunities and Advances Inhaled Therapeutic Pipeline

Minichart

March 2, 2026

Pulmatrix Terminates Cullgen Merger, Pursues Alternative Opp...

Continue Reading 0

us corporate news

BSTR Holdings, Inc. Investor Presentation: Bitcoin Treasury Strategy, Capital Stack, and Risk Factors (2026)

Minichart

March 2, 2026

BSTR Holdings, Inc. Investor Presentation – Key Insights for...

Continue Reading 0

us corporate news

NETSTREIT Corp. Investor Presentation March 2026: Portfolio Strategy, Acquisition Approach, and Real Estate Valuation 6910

Minichart

March 2, 2026

NETSTREIT Corp. Releases March 2026 Investor Presentation: K...

Continue Reading 0

us corporate news

Farmers National Banc Corp. (FMNB) Files Form 8-K: Company and Security Details for March 2026

Minichart

March 2, 2026

Farmers National Banc Corp. (FMNB) Completes Acquisition of ...

Continue Reading 0

us corporate news

UroGen Pharma Ltd. Enters $250 Million Loan Agreement with BioPharma Credit – SEC 8-K Filing Summary

Minichart

March 2, 2026

UroGen Pharma Ltd. Enters \$250 Million Loan Agreement: Key ...

Continue Reading 0

us corporate news

UroGen Pharma Reports 2025 Financial Results and ZUSDURI™ FDA Launch Progress, Provides Business Update

Minichart

March 2, 2026

UroGen Pharma Reports Q4 and Full Year 2025 Financial Result...

Continue Reading 0